Page last updated: 2024-08-23
7-n-(4-hydroxyphenyl)mitomycin c and Carcinoma, Bronchogenic
7-n-(4-hydroxyphenyl)mitomycin c has been researched along with Carcinoma, Bronchogenic in 1 studies
*Carcinoma, Bronchogenic: Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA. [MeSH]
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fujioka, Y; Hoshi, A; Saijo, N; Shibuya, M; Shimizu, E; Takizawa, T | 1 |
Other Studies
1 other study(ies) available for 7-n-(4-hydroxyphenyl)mitomycin c and Carcinoma, Bronchogenic
Article | Year |
---|---|
[In vitro antitumor activity of 7-N-(p-hydroxyphenyl)-mitomycin C (KW-2083) against cultured bronchogenic carcinoma cells (PC-7)].
Topics: Carcinoma, Bronchogenic; Cell Line; Cells, Cultured; Drug Evaluation; Humans; Lung Neoplasms; Mitomycin; Mitomycins | 1983 |